RADU, CLAUDIA-MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.039
AS - Asia 5.355
EU - Europa 2.489
SA - Sud America 856
AF - Africa 830
OC - Oceania 85
Continente sconosciuto - Info sul continente non disponibili 43
Totale 19.697
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.562
SG - Singapore 1.715
CN - Cina 968
VN - Vietnam 918
IT - Italia 589
BR - Brasile 527
HK - Hong Kong 476
DE - Germania 285
FI - Finlandia 221
FR - Francia 160
IN - India 144
SE - Svezia 143
GB - Regno Unito 140
BD - Bangladesh 132
PL - Polonia 125
NL - Olanda 104
IQ - Iraq 82
TR - Turchia 77
AR - Argentina 73
RU - Federazione Russa 72
JP - Giappone 69
CA - Canada 60
PH - Filippine 54
ZA - Sudafrica 54
PK - Pakistan 53
UA - Ucraina 53
MX - Messico 50
SA - Arabia Saudita 47
EC - Ecuador 46
ES - Italia 43
AT - Austria 42
BJ - Benin 39
CO - Colombia 38
ID - Indonesia 35
CL - Cile 34
GR - Grecia 34
AZ - Azerbaigian 33
EG - Egitto 33
UZ - Uzbekistan 33
VE - Venezuela 33
IE - Irlanda 32
PA - Panama 32
TH - Thailandia 32
DZ - Algeria 31
AE - Emirati Arabi Uniti 30
JM - Giamaica 30
KR - Corea 30
PY - Paraguay 30
ET - Etiopia 29
JO - Giordania 29
NP - Nepal 29
DO - Repubblica Dominicana 28
MY - Malesia 28
NI - Nicaragua 28
SN - Senegal 28
CI - Costa d'Avorio 27
KG - Kirghizistan 27
MA - Marocco 27
IL - Israele 26
LV - Lettonia 26
LY - Libia 26
AO - Angola 25
IR - Iran 25
UG - Uganda 25
HU - Ungheria 24
KE - Kenya 24
PE - Perù 24
TW - Taiwan 24
BF - Burkina Faso 23
ML - Mali 23
MR - Mauritania 23
PS - Palestinian Territory 23
RE - Reunion 23
RO - Romania 23
UY - Uruguay 23
YT - Mayotte 23
AU - Australia 22
CH - Svizzera 22
CW - ???statistics.table.value.countryCode.CW??? 22
CZ - Repubblica Ceca 22
LB - Libano 22
TN - Tunisia 22
BZ - Belize 21
HN - Honduras 21
LA - Repubblica Popolare Democratica del Laos 21
MN - Mongolia 21
MW - Malawi 21
PR - Porto Rico 21
BE - Belgio 20
BY - Bielorussia 20
CR - Costa Rica 20
HT - Haiti 20
AL - Albania 19
BW - Botswana 19
CY - Cipro 19
GT - Guatemala 19
IS - Islanda 19
LC - Santa Lucia 19
MG - Madagascar 19
NC - Nuova Caledonia 19
Totale 18.846
Salva come PNG Salva come JPEG
Città #
Ashburn 1.203
San Jose 1.100
Singapore 1.069
Fairfield 1.001
Woodbridge 685
Chandler 540
Ann Arbor 466
Hong Kong 427
Houston 405
Seattle 399
Wilmington 346
Cambridge 327
Ho Chi Minh City 269
Beijing 232
Los Angeles 210
Hanoi 200
Santa Clara 189
Boardman 139
Chicago 128
Jacksonville 128
Padova 113
Helsinki 112
San Diego 102
Princeton 98
Lauterbourg 87
Munich 87
New York 82
Des Moines 70
Medford 68
Bytom 64
Buffalo 57
São Paulo 55
Council Bluffs 54
Da Nang 53
Dong Ket 53
Milan 47
Orem 45
Roxbury 44
The Dalles 44
Tokyo 44
London 43
Salt Lake City 42
Turku 41
Warsaw 41
Haiphong 40
Cotonou 39
Hefei 39
Dallas 36
Nanjing 33
Baku 31
Padua 31
Villafranca Padovana 31
Panama City 30
Brooklyn 29
Rio de Janeiro 29
Baghdad 28
Dakar 28
Montreal 28
Tashkent 28
Frankfurt am Main 27
Nuremberg 27
Stockholm 27
Addis Ababa 26
Elk Grove Village 26
Guangzhou 26
Managua 26
Vienna 26
Abidjan 25
Athens 25
Denver 25
Istanbul 25
Atlanta 24
Dublin 24
Tampa 24
Amman 23
Amsterdam 23
Kampala 23
Phoenix 23
Bamako 22
Bishkek 22
Kingston 22
Luanda 22
Nouakchott 21
Ulan Bator 21
Johannesburg 20
Montevideo 20
Cairo 19
Jeddah 19
Nairobi 19
Noumea 19
Shanghai 19
Shenyang 19
Willemstad 19
Antananarivo 18
Cape Town 18
Castries 18
Lusaka 18
Riga 18
Rome 18
Gaborone 17
Totale 12.392
Salva come PNG Salva come JPEG
Nome #
Profiling plasma alterations of extracellular vesicles in patients with acutely decompensated cirrhosis and bacterial infection 342
Dynamics of circulating microparticles in obesity after weight loss 335
Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles? 319
miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways 310
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 298
Peculiar whole blood rotation thromboelastometry (Rotem) profile in 40 sideropenic anaemia patients 284
Procoagulant phenotype of virus-infected pericytes is associated with portal thrombosis and intrapulmonary vascular dilations in fatal COVID-19 281
Critical review of the evolution of extracellular vesicles’ knowledge: From 1946 to today 280
Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity 279
X-linked thrombophilia with a mutant factor IX (factor IX Padua). 279
Necroptosis-driving genes RIPK1, RIPK3 and MLKL-p are associated with intratumoral CD3+ and CD8+ T cell density and predict prognosis in hepatocellular carcinoma 275
Incidence of VTE in asymptomatic children with deficiencies of antithrombin, protein C, and protein S: a prospective cohort study 275
Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells 267
Anti-platelet factor 4 antibody-mediated disorders: an updated narrative review 264
Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance 259
Effects of long-term administration of recombinant human protein C in xenografted primates. 259
Macrophage-secreted myogenic factors: a promising tool for greatly enhancing the proliferative capacity of myoblasts in vitro and in vivo 254
Potential role of thrombelastography in the monitoring of acquired factor VIII inhibitor hemophilia A: report on a 78-year-old woman with life-threatening bleedings. 252
Circulating microparticles in pregnant patients with primary anti-phospholipid syndrome: an exploratory study 248
The GIP/GIPR axis in medullary thyroid cancer: clinical and molecular findings 248
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study 245
Albumin uptake in human podocytes: A possible role for the cubilin-amnionless (CUBAM) complex 241
Poly(lipoic acid)-based nanoparticles as a new therapeutic tool for delivering active molecules 239
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma 236
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study 234
Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals 233
First Evidence of Mineralocorticoid Receptor Gene and Protein Expression in Rat and Human Thyroid Tissues and Cell Cultures 227
Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role. 226
Microparticles as biomarkers of venous thromboembolic events 224
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis 224
Endometriotic Follicular Fluid Affects Granulosa Cells’ Morphology and Increases Duplication Rate and Connexin-43 Expression 221
Exogenous human α-Synuclein acts in vitro as a mild platelet antiaggregant inhibiting α-thrombin-induced platelet activation 217
Circulating glial-derived and tissue factor bearing microparticles in patients with high grade glioma 216
Partial F8 gene duplication (Factor VIII Padua) associated with high factor VIII levels and familial thrombophilia 216
Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S 215
Human parietal epithelial cells (PECs) and proteinuria in lupus nephritis: a role for ClC-5, megalin, and cubilin? 214
Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events 214
Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia 213
Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis 210
Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis 210
Enhancing myoblast proliferation by using myogenic factors: a promising approach for improving fiber regeneration in sport medicine and skeletal muscle diseases 208
Thrombin generation in patients with COVID-19 with and without thromboprophylaxis 208
MP062 EXPLORING ALBUMIN UPTAKE IN HUMAN PODOCYTES: A POSSIBLE INVOLVEMENT FOR THE TUBULAR UPTAKE MACHINERY 206
Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women 205
PAR-4/Ca2+-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes. 204
Platelet factor V levels in moderate to severe congenital factor V deficiency. 199
Microvesicles in bronchoalveolar lavage as a potential biomarker of COPD 199
The haemostatic system in acromegaly: a single-centre case–control study 194
Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19 192
Increased Soluble Interleukin 6 Receptors in Fabry Disease 190
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct acting antivirals 189
Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. 189
New prothrombin mutation (Arg596Trp, Prothrombin Padua 2) associated with venous thromboembolism 187
Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis. 186
Human parietal epithelial cells as Trojan horses in albumin overload 185
Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms 184
Whole blood rotation thromboelastometry (ROTEM(®)) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V. 184
Levels of circulating microparticles in septic shock and sepsis-related complications: A case-control study 182
Immunization with Pentraxin3 prevents transition from subclinical to clinical lupus nephritis in lupus-prone mice: insights from renal ultrastructural findings.   181
Anti-CTLA-and anti-PD-1 immune checkpoint inhibitor antibodies impair human sperm motility in-vitro 179
Macrophages-derived Factor XIII links coagulation to inflammation in COPD 179
Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis. 179
Additive effect of Bisphenol A and Pefluoro-sulphoctanoic acid exposure at subacute toxic levels, on a murine model of sertoli cell 178
Tailored prophylaxis with rFXIII (NovoThirteen ® ) in a young girl with severe FXIII deficiency and previous cephalohaematoma 178
Thromboelastographic evaluation of coagulative profiles in pig-to-monkey kidney xenotransplantation. 177
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study 175
Evaluation of a procoagulant phospholipid functional assay as a routine test for measuring circulating microparticle activity. 174
Study of the origin of platelets coagulation protein S by human megakaryocyte cultures and characterization of platelets protein S in patients with inherited protein S deficiency 173
Antisense-based RNA therapy of factor V deficiency: in vitro and ex vivo rescue of a F5 deep-intronic splicing mutation. 172
Modulating thrombotic diathesis in hereditary thrombophilia and antiphospholipid antibody syndrome: A role for circulating microparticles? 171
Studies on coagulation incompatibilities for xenotransplantation. 170
[Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with rheumatic diseases]. 168
Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. 167
Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia 167
Reticulated platelets are increased and hyper-activated in patients with cirrhosis, especially those with poor outcome 167
Increased Cardiovascular Risk Associated with Chemical Sensitivity to Perfluoro-Octanoic Acid: Role of Impaired Platelet Aggregation 164
Sounds Stimulation on In Vitro HL1 Cells: A Pilot Study and a Theoretical Physical Model 164
The antiproliferative effects of ouabain and everolimus on adrenocortical tumor cells. 162
Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis. 161
Association between increased FVIIa-antithrombin complex/FVIIa ratio and pre-eclampsia. 161
Thrombin activatable fibrinolysis inhibitor in cancer patients with and without venous thromboembolism. 159
Reference values for thromboelastometry (ROTEM®) in cynomolgus monkeys (Macaca fascicularis). 159
Evaluation of necroptosis related genes RIPK1, RIPK3 and MLKL-p immunogenicity in hepatocellular carcinoma 157
Thrombin generation and thromboelastometry in monitoring the in-vitro reversal of warfarin: A comparison between 3-factor and 4-factor prothrombin complex concentrates 157
Inherited thrombophilia and venous thromboembolism 156
Similar hypercoagulable state and thrombosis risk in type I and type III proteinS-deficient individuals from mixed type I/III families. 156
Thromboelastometry profiles after “in vitro” addition of a new plasma-derived factor V concentrate to whole blood from parahaemophilia patients 156
Similar hypercoagulable state and thrombosis risk in type Iand type III protein S-deficient individuals from families with mixed type I/IIIprotein S deficiency. 154
Circulating microparticles in carriers of prothrombin G20210A mutation. 147
The aggressive EpCAM+CD45+ phenotype in serous epithelial ovarian cancer 147
Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma 145
Exploring albumin uptake in human podocytes: a possible involvement of the tubular endocytic machinery 143
Whole blood coagulation assessment using novel rotational thromboelastometry (ROTEM-R) in seen naive cynomologus monkeys 118
Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology 117
Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with rheumatic diseases. 114
Thrombin generation profile in cynomolgus monkey recipients of porcine neuronal xenograft 110
CHARACTERIZATION OF CIRCULATING MICROPARTICLES DURING NORMAL PREGNANCY 106
Coagulation profile in cynomolgus monkey recipients of porcine neuronal xenograft: a preliminary study 101
Progesterone and IL-6 Expression Are Modulated by Follicular Fluid in Granulosa Cell Cultures 7
Totale 19.850
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.582
article - articoli 52.731
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.313
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021179 0 0 0 0 0 0 0 0 0 0 0 179
2021/20221.244 52 73 160 92 95 103 39 170 78 26 101 255
2022/20231.043 175 115 31 143 174 115 6 71 136 11 51 15
2023/2024547 31 78 57 56 39 67 43 43 18 25 40 50
2024/20252.485 5 156 102 93 316 84 151 196 214 99 450 619
2025/202610.433 503 866 1.223 1.633 1.108 499 1.567 861 1.155 546 431 41
Totale 19.850